Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit
MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer, will present at the 7th Annual Truist Securities Life Sciences Summit on Tuesday, May 4, 2021 at 2:40 PM ET.
A live audio webcast of the fireside chat can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com. An archived replay will be available for 30 days following the presentation.
About Adicet Bio, Inc.
Adicet Bio., Inc.
Great Customer Outcomes: A Balance Between Automation & Empathy
Keynote Presentation by Zoom
Exhibit Hall Open